References
- Vital Statistics First Quarter 2017 – CSO – Central Statistics Office. In: Live Register January 2017 – CSO – Central Statistics Office. http://www.cso.ie/en/releasesandpublications/ep/p-vs/vitalstatisticsfirstquarter2017/.
- Department of Health, Ireland. Report of the Commission on Assisted Human Reproduction. 2018 In: Lenus.ie. http://www.lenus.ie/hse/handle/10147/46684.
- Gould J, Overstreet J, Hanson F. Assessment of human sperm function after recovery from the female reproductive tract. Biol Reprod. 1984; 31:888–894.
- Lindsay TJ, Vitrikas KR. Evaluation and treatment of infertility. Am Fam Physician. 2015;91:308–314.
- Somigliana E, Paffoni A, Busnelli A, et al. Age-related infertility and unexplained infertility an intricate clinical dilemma. Hum Reprod. 2016;31:1390–1396.
- Cooper TG, Noonan E, von Eckardstein S, et al. World Health Organization reference values for human semen characteristics. Hum Reprod Update. 2010;16:231–245.
- National Collaborating Centre for Women’s and Children’s Health (UK) Fertility: assessment and treatment. NICE 2017 https://www.nice.org.uk/guidance/cg156/chapter/Recommendations#investigation-of-fertility-problems-and-management-strategies.
- Keck C, Bassett R, Ludwig M. Factors influencing response to ovarian stimulation. Reprod BioMed Online. 2005;11:562–569.
- Kosmas I, Tatsioni A, Fatemi H, et al. Human chorionic gonadotropin administration vs. luteinizing monitoring for intrauterine insemination timing, after administration of clomiphene citrate: a meta-analysis. Fertil Steril. 2007; 87:607–612.
- Veltman-Verhulst SM, Cohlen BJ, Hughes E, et al. Intra-uterine insemination for unexplained subfertility. Cochrane Database Syst Rev. 2012;12:CD001838.
- Manders M, McLindon L, Schulze B, et al. Timed intercourse for couples trying to conceive. Cochrane Database Syst Rev. 2015;32:CD011345.
- Balen AH, Morley LC, Misso M, et al. The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance. Hum Reprod Update. 2016;22:687–708.
- Franik S, Kremer JA, Nelen WL, et al. Aromatase inhibitors for subfertile women with polycystic ovary syndrome: summary of a Cochrane review. Fertil Steril. 2015;103:353–355.
- Nandi A, Bhide P, Hooper R, et al. Intrauterine insemination with gonadotropin stimulation or in vitro fertilization for the treatment of unexplained subfertility: a randomized controlled trial. Fertil Steril. 2017;107:1329–1335.e2.
- Ray A, Shah A, Gudi A, et al. Unexplained infertility: an update and review of practice. Reprod Biomed Online. 2012;24:591–602.
- Berker B, Kahraman K, Taskin S, et al. Recombinant FSH versus clomiphene citrate for ovarian stimulation in couples with unexplained infertility and male subfertility undergoing intrauterine insemination: a randomized trial. Arch Gynecol Obstet. 2011;284:1561–1566.
- Kabli N, Sylvestre C, Tulandi T, et al. Comparison of daily and alternate day recombinant follicle-stimulating hormone stimulation protocols for intrauterine insemination. Fertil Steril. 2009;91:1141–1144.
- McFaul PB, Traub AI, Sheridan B, et al. Daily or alternate-day FSH therapy in patients with polycystic ovarian disease resistant to clomiphene citrate treatment. Int J Fertil. 1989;34:194–198.
- Ombelet W, Dhont N, Thijssen A, et al. Semen quality and prediction of IUI success in male subfertility: a systematic review. Reprod BioMed Online. 2014;28:300–309.
- Cohlen B, Bijkerk A, Van der Poel S, et al. IUI: review and systematic assessment of the evidence that supports global recommendations. Hum Reprod Update. 2018;24:300–319.